Osteoclast inhibitors | ПРЕЦИЗИОННАЯ ОНКОЛОГИЯ

Osteoclast inhibitors

Uptodate 2015

Osteoclast inhibitors, including bisphosphonates and denosumab slow or reverse the progression of skeletal metastases. These agents are widely used in the treatment of patients with bone metastases from breast cancer, multiple myeloma, and other solid tumors, including prostate cancer and non-small cell lung cancer.